MLAB Mesa Laboratories Inc

  1. Stocks
  2. Technology
  3. NASDAQ: MLAB

Price (delayed)

$103.19

Market cap

$556.61M

P/E Ratio

607

Dividend/share

$0.64

EPS

$0.17

Enterprise value

$761.35M

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. ...

Highlights
Mesa Laboratories's net income has surged by 165% YoY
The company's EPS has surged by 161% YoY
The debt has grown by 36% from the previous quarter and by 23% YoY
The company's quick ratio fell by 20% QoQ and by 12% YoY
Sector: Technology
Industry: Scientific & Technical Instruments
Website: http://www.mesalabs.com
Peers: TMO HBIO AME STE

Key stats

What are the main financial stats of MLAB
Market
Shares outstanding
5.39M
Market cap
$556.61M
Enterprise value
$761.35M
Valuations
Price to earnings (P/E)
607
Price to book (P/B)
1.38
Price to sales (P/S)
2.61
EV/EBIT
165.66
EV/EBITDA
19.56
EV/Sales
3.58
Earnings
Revenue
$212.87M
EBIT
$4.6M
EBITDA
$38.93M
Free cash flow
$40.71M
Per share
EPS
$0.17
Free cash flow per share
$7.55
Book value per share
$74.74
Revenue per share
$39.47
TBVPS
$30.19
Balance sheet
Total assets
$741.77M
Total liabilities
$338.81M
Debt
$232.97M
Equity
$402.96M
Working capital
$74.17M
Liquidity
Debt to equity
0.58
Current ratio
2.68
Quick ratio
1.45
Net debt/EBITDA
5.26
Margins
EBITDA margin
18.3%
Gross margin
61%
Net margin
0.4%
Operating margin
1.9%
Efficiency
Return on assets
0.1%
Return on equity
0.2%
Return on invested capital
1.7%
Return on capital employed
0.7%
Return on sales
2.2%
Dividend
Dividend yield
0.62%
DPS
$0.64
Payout ratio
376.5%

MLAB stock price

How has the Mesa Laboratories stock price performed over time
Intraday
1.37%
1 week
2.43%
1 month
0.83%
1 year
-35.9%
YTD
-1.51%
QTD
-5.96%

Financial performance

How have Mesa Laboratories's revenue and profit performed over time
Revenue
$212.87M
Gross profit
$129.9M
Operating income
$4.01M
Net income
$948,000
Gross margin
61%
Net margin
0.4%
Mesa Laboratories's net income has surged by 165% YoY
The net margin has soared by 157% YoY
The operating margin has grown by 36% YoY and by 27% from the previous quarter
MLAB's operating income is up by 27% YoY and by 22% from the previous quarter

Growth

What is Mesa Laboratories's growth rate over time

Valuation

What is Mesa Laboratories stock price valuation
P/E
607
P/B
1.38
P/S
2.61
EV/EBIT
165.66
EV/EBITDA
19.56
EV/Sales
3.58
The company's EPS has surged by 161% YoY
MLAB's price to book (P/B) is 58% less than its 5-year quarterly average of 3.3 and 23% less than its last 4 quarters average of 1.8
MLAB's equity is up by 4.1% year-on-year and by 3.9% since the previous quarter
The P/S is 64% below the 5-year quarterly average of 7.3 and 18% below the last 4 quarters average of 3.2
MLAB's revenue is down by 4.3% year-on-year

Efficiency

How efficient is Mesa Laboratories business performance
The return on assets has surged by 200% since the previous quarter and by 150% year-on-year
MLAB's return on equity has surged by 200% since the previous quarter and by 150% year-on-year
The company's return on sales rose by 22% QoQ and by 10% YoY
Mesa Laboratories's return on invested capital has increased by 13% QoQ and by 6% YoY

Dividends

What is MLAB's dividend history
DPS
$0.64
Dividend yield
0.62%
Payout ratio
376.5%
Recent dividends

Financial health

How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 119% more than its total liabilities
The total liabilities has grown by 36% from the previous quarter and by 23% YoY
The company's quick ratio fell by 20% QoQ and by 12% YoY
The debt is 42% less than the equity
The debt has grown by 36% from the previous quarter and by 23% YoY
MLAB's debt to equity is up by 32% QoQ and by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.